淋巴介入的研究优先方向:多学科研究共识专家组的建议
介入放射学会基金会于2020年2月21日召集淋巴医学多学科研究共识专家组,讨论并依据临床相关性、总体影响与技术可行性对研究优先方向排序。专家组优先方向包括:充血性心力衰竭患者的淋巴减压、急性疾病中胸导管淋巴的解毒、新型淋巴成像剂的研发、器官淋巴成分表征以及肝硬化腹水淋巴介入治疗的开发。
要点
- 专家组将心力衰竭淋巴减压列为优先研究方向。
- 胸导管淋巴解毒与肝硬化腹水介入治疗同为重点方向。
- 淋巴系统在心力衰竭、肝硬化及危重症中可能起重要作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Recognizing the increasing importance of lymphatic interventions, the Society of Interventional Radiology Foundation brought together a multidisciplinary group of key opinion leaders in lymphatic medicine to define the priorities in lymphatic research. On February 21, 2020, SIRF convened a multidisciplinary Research Consensus Panel (RCP) of experts in the lymphatic field. During the meeting, the panel and audience discussed potential future research priorities. The panelists ranked the discussed research priorities based on clinical relevance, overall impact, and technical feasibility. The following research topics were prioritized by RCP: lymphatic decompression in patients with congestive heart failure, detoxification of thoracic duct lymph in acute illness, development of newer agents for lymphatic imaging, characterization of organ-based lymph composition, and development of lymphatic interventions to treat ascites in liver cirrhosis. The RCP priorities underscored that the lymphatic system plays an important role not only in the intrinsic lymphatic diseases but in conditions that traditionally are not considered to be lymphatic such as congestive heart failure, liver cirrhosis, and critical illness. The advancement of the research in these areas will lead the field of lymphatic interventions to the next level.
引用
- Itkin M, Rockson SG, Witte MH, et al. Research Priorities in Lymphatic Interventions: Recommendations from a Multidisciplinary Research Consensus Panel. J Vasc Interv Radiol. 2021. PMID: 33610432. doi:10.1016/j.jvir.2021.01.269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。